Volume 10, Number 6—June 2004
Dispatch
SARS and Common Viral Infections
Janice K. Louie*†1
, Jill K. Hacker*1, Jennifer Mark*, Shilpa S. Gavali*, Shigeo Yagi†, Alex Espinosa†, David P. Schnurr†, Cynthia K. Cossen†, Erin R. Isaacson†, Carol A. Glaser†, Marc Fischer‡, Arthur L. Reingold†, Duc J. Vugia*†, and for the Unexplained DeathsCritical Illnesses Working Group
, Jill K. Hacker*1, Jennifer Mark*, Shilpa S. Gavali*, Shigeo Yagi†, Alex Espinosa†, David P. Schnurr†, Cynthia K. Cossen†, Erin R. Isaacson†, Carol A. Glaser†, Marc Fischer‡, Arthur L. Reingold†, Duc J. Vugia*†, and for the Unexplained DeathsCritical Illnesses Working Group
Table 3
Summary of positive laboratory results at the California Department of Health Services by CDC case criteriaa,b
| Total (N = 165) |
Suspect (N = 51) |
Probable (N = 19) |
Confirmed (N = 2) |
Non-SARS cases (N = 94) |
|
|---|---|---|---|---|---|
| Pathogen | n (%) | n (%) | n (%) | n (%) | n (%) |
| Influenza A | 28 (17)c | 11 (22) | 4 (21) | 0 | 13 (14) |
| Influenza B | 2 (1) | 1 (2) | 0 | 0 | 1 (1) |
| Respiratory syncytial virus | 6 (4) | 1 (2) | 0 | 0 | 5 (5) |
| Parainfluenza virus types 2–4 | 6 (5) | 1 (2) | 0 | 0 | 5 (5) |
| Human metapneumovirus | 11 (7) | 4 (8) | 2 (11) | 0 | 5 (5) |
| Coronavirus OC43 | 1 (1) | 0 | 0 | 0 | 1 (0) |
| Coronavirus 229E | 0 | 0 | 0 | 0 | 0 |
| Parainfluenza virus type 1 | 0 | 0 | 0 | 0 | 0 |
| Adenovirus | 1 (1) | 1 (2) | 0 | 0 | 0 |
| Picornavirus | 12 (7) | 4 (8) | 0 | 0 | 8 (9) |
| Mycoplasma pneumoniae | 3 (2)c | 0 | 2 (11) | 0 | 1 (1) |
| Chlamydia spp. | 1 (1) | 0 | 1 (5) | 0 | 0 |
| SARS-CoVd | 2 (1) | 0 | 2 (100) | 0 | |
| Total positive | 73 (44) | 23 (45) | 9 (47) | 2 (100) | 39 (42) |
aUsing criteria for suspect, probable, or laboratory-confirmed severe acute respiratory syndrome (SARS) recommended by the Centers for Disease Control and Prevention (CDC).
b Includes polymerase chain reaction (PCR), culture, and serologic tests.
cOne patient had evidence of co-infection with both influenza A (PCR and culture) and M. pneumoniae (immunoglobulin [Ig] M detection).
dSARS-CoV, SARS-associated coronavirus.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.